Advertisement
Advertisement
ESPR
Esperion Therapeutics, Inc.
1.58
USD-0.13
-7.35%
Mar 03, 15:52 UTC -5
Closed
After-Market
1.61
+0.04
+2.22%
Esperion Therapeutics, Inc. Profile
About
Info & Links
CEO
Sheldon L. Koenig
Headquarters
ANN ARBOR, MI 48108, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & YoungLLP
Share holders
5
Employees
240
Esperion Therapeutics, Inc. Statistics
Valuation Measures
Market Capitalization2
305.03M
Enterprise Value
423.24M
Enterprise Value/EBITDA(ttm)
23.19
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
1.23
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
75.64%
Operating Margin(ttm)
-11.35%
Profit Margin(ttm)
-67.86%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
-56.72%
Return on Assets(ttm)
-10.77%
Income Statement
Revenue(ttm)
295.45M
Revenue Per Share(ttm)
1.50
Gross Profit(ttm)
241.03M
EBITDA(ttm)3
18.25M
Net Income Available to Common(ttm)
-86.77M
Diluted EPS(ttm)
-0.64
Share Statistics
Beta (5Y Monthly)
1.01
52-Week Change
-38.24%
S&P 500 52-Week Change
14.01%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
197.04M
Dividend Yield
0.00%
Float4
195.06M
% Held by Insiders
1.00%
% Held by Institutions
47.39%
Balance Sheet
Total Cash(mrq)
144.72M
Total Cash Per Share(mrq)
0.73
Total Debt(mrq)
262.92M
Total Debt/Equity(mrq)
-71.02%
Current Ratio(mrq)
1.85%
Quick Ratio(mrq)
1.37%
Book Value Per Share(mrq)
-1.88
Cash Flow
Operating Cash Flow Per Share(ytd)
0.06
Free Cash Flow(ytd)
10.98M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement